Q1 2025 Zydus Lifesciences Ltd Earnings Call Transcript
Good afternoon, everyone. Welcome to Zydus Lifesciences Limited quarter-one FY25 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
And I now hand over the conference to Mr. Ganesh Nayak, Executive Director of Zydus Lifesciences. Thank you, and over to you.
Good afternoon, ladies and gentlemen. Welcome to our post-results teleconference for the quarter ended June 30, 2024. For today's call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Arvind Bothra, Senior Vice President, Investor Relations; and Mr. Alok Garg, Senior Vice President from the Managing Director's office.
Let me now give you a broad overview of the developments during the quarter. It's my pleasure to share that we commenced fiscal 2025 on a strong note, sustaining the growth momentum across the businesses during the quarter. Overall, we delivered a strong double-digit growth during the quarter.
This, coupled
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |